GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Gushengtang Holdings Ltd (HKSE:02273) » Definitions » EV-to-EBITDA

Gushengtang Holdings (HKSE:02273) EV-to-EBITDA : 19.71 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gushengtang Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Gushengtang Holdings's enterprise value is HK$9,268 Mil. Gushengtang Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$470 Mil. Therefore, Gushengtang Holdings's EV-to-EBITDA for today is 19.71.

The historical rank and industry rank for Gushengtang Holdings's EV-to-EBITDA or its related term are showing as below:

HKSE:02273' s EV-to-EBITDA Range Over the Past 10 Years
Min: -43.46   Med: 20.05   Max: 36.49
Current: 19.84

During the past 6 years, the highest EV-to-EBITDA of Gushengtang Holdings was 36.49. The lowest was -43.46. And the median was 20.05.

HKSE:02273's EV-to-EBITDA is ranked worse than
72.08% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 12.675 vs HKSE:02273: 19.84

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), Gushengtang Holdings's stock price is HK$42.45. Gushengtang Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.127. Therefore, Gushengtang Holdings's PE Ratio for today is 37.67.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Gushengtang Holdings EV-to-EBITDA Historical Data

The historical data trend for Gushengtang Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gushengtang Holdings EV-to-EBITDA Chart

Gushengtang Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - -17.44 30.06 24.17

Gushengtang Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.44 - 30.06 - 24.17

Competitive Comparison of Gushengtang Holdings's EV-to-EBITDA

For the Medical Care Facilities subindustry, Gushengtang Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gushengtang Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gushengtang Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Gushengtang Holdings's EV-to-EBITDA falls into.



Gushengtang Holdings EV-to-EBITDA Calculation

Gushengtang Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9268.268/470.22
=19.71

Gushengtang Holdings's current Enterprise Value is HK$9,268 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gushengtang Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$470 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gushengtang Holdings  (HKSE:02273) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Gushengtang Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=42.45/1.127
=37.67

Gushengtang Holdings's share price for today is HK$42.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gushengtang Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.127.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Gushengtang Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Gushengtang Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Gushengtang Holdings (HKSE:02273) Business Description

Traded in Other Exchanges
N/A
Address
No. 419, Qingsha Road, Room 005, Dongchong Town, Nansha District, Guangzhou, CHN
Gushengtang Holdings Ltd is a traditional Chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. As all of the Group's revenue is derived from the PRC.
Executives
Tu Zhiliang 2501 Other
Wumianshan Ltd. 2201 Interest of corporation controlled by you
Frandor Limited
Tu Family Holdings Limited
Trident Trust Company (singapore) Pte. Limited
Dream True Limited
Action Thrive Group Limited 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Eight Roads Holdings Limited 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Eight Roads Shareholdings Limited 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Johnson Iv Edward C. 2301 Trustee
Johnson Abigail P. 2301 Trustee

Gushengtang Holdings (HKSE:02273) Headlines

No Headlines